ConductScience.org, home

Paper39289508

Silencing the transcriptionally active HIV reservoir to improve treatment outcomes.

Prigann J and 9 others. Nat Microbiol, 2024. Cited by 11 papers, by iCite.

Cite this record

ConductScience Library. Silencing the transcriptionally active HIV reservoir to improve treatment outcomes. Papers, record 39289508. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39289508

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Silencing the transcriptionally active HIV reservoir to improve treatment outcomes.
PubMed
Journal
Nat Microbiol
PubMed
Year
2024
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
11
iCite
Relative citation ratio, by iCite
1.39, provisional
iCite
Revised in PubMed
2025-07-21
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Prigann JJulia
2Tavora RRubens
3Furler O'Brien RLRobert Lhttps://orcid.org/0000-0001-5706-4871
4Schulze-Gahmen UUrsulahttps://orcid.org/0000-0003-3919-4474
5Boehm DDaniela
6Roan NRNadia Rhttps://orcid.org/0000-0002-5464-1976
7Nixon DFDouglas Fhttps://orcid.org/0000-0002-2801-1786
8Ndhlovu LCLishomwa Chttps://orcid.org/0000-0001-5427-4187
9Valente SSusana
10Ott MMelaniehttps://orcid.org/0000-0002-5697-1274

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
HIV InfectionsMajor topic
HIV-1Major topic
Humans
Treatment Outcome
Virus Latency
Transcription, Genetic
Anti-HIV Agents
CD4-Positive T-Lymphocytes

Source PubMed

Download CSV of topics

Grants4

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
R01 AI167732NIAID NIH HHSUnited StatesR01AI167732PubMedNIH RePORTER
R37 AI165137NIAID NIH HHSUnited StatesR37AI165137PubMedNIH RePORTER
UM1 AI164559NIAID NIH HHSUnited StatesUM1AI164559PubMed and NIHNIH RePORTER
UM1AI164559U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (NIAID)UM1AI164559PubMed and NIHNIH RePORTER

Download CSV of grants

References15

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
132573496Filgotinib suppresses HIV-1-driven gene transcription by inhibiting HIV-1 splicing and T cell activation.J Clin Invest2020https://conductscience.org/library/papers/32573496PubMed
222817991An analog of the natural steroidal alkaloid cortistatin A potently suppresses Tat-dependent HIV transcription.Cell Host Microbe2012https://conductscience.org/library/papers/22817991PubMed
336599978HIV silencing and cell survival signatures in infected T cell reservoirs.Nature2023https://conductscience.org/library/papers/36599978PubMed
429491188HIV latency in isolated patient CD4+ T cells may be due to blocks in HIV transcriptional elongation, completion, and splicing.Sci Transl Med2018https://conductscience.org/library/papers/29491188PubMed
536599977Phenotypic signatures of immune selection in HIV-1 reservoir cells.Nature2023https://conductscience.org/library/papers/36599977PubMed
636146786Forging a Functional Cure for HIV: Transcription Regulators and Inhibitors.Viruses2022https://conductscience.org/library/papers/36146786PubMed
738035854
Plasma Human Immunodeficiency Virus 1 Soluble Glycoprotein 120 Association With Correlates of Immune Dysfunction and Inflammation in Antiretroviral Therapy-Treated Individuals With Undetectable Viremia.
J Infect Dis2024https://conductscience.org/library/papers/38035854PubMed
832029589Defective HIV-1 proviruses produce viral proteins.Proc Natl Acad Sci U S A2020https://conductscience.org/library/papers/32029589PubMed
935026153Parallel analysis of transcription, integration, and sequence of single HIV-1 proviruses.Cell2022https://conductscience.org/library/papers/35026153PubMed
1029045830In Vivo Suppression of HIV Rebound by Didehydro-Cortistatin A, a "Block-and-Lock" Strategy for HIV-1 Treatment.Cell Rep2017https://conductscience.org/library/papers/29045830PubMed
1133239456The XPB Subunit of the TFIIH Complex Plays a Critical Role in HIV-1 Transcription and XPB Inhibition by Spironolactone Prevents HIV-1 Reactivation from Latency.J Virol2021https://conductscience.org/library/papers/33239456PubMed
1230546110Intron-containing RNA from the HIV-1 provirus activates type I interferon and inflammatory cytokines.Nat Commun2018https://conductscience.org/library/papers/30546110PubMed
1328416661Single-cell analysis of HIV-1 transcriptional activity reveals expression of proviruses in expanded clones during ART.Proc Natl Acad Sci U S A2017https://conductscience.org/library/papers/28416661PubMed
1427681137Specific Inhibition of HIV Infection by the Action of Spironolactone in T Cells.J Virol2016https://conductscience.org/library/papers/27681137PubMed
1533075121HIV-1 Transcription but Not Intact Provirus Levels are Associated With Systemic Inflammation.J Infect Dis2021https://conductscience.org/library/papers/33075121PubMed

Download CSV of references

Cited by8

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 11 citations.

PMIDTitleJournalYearIn PapersSource
42927123"Locking" CDK9 inhibition by activating integrator function in HIV transcription.iScience2026https://conductscience.org/library/papers/42927123PubMed
42900669Selective persistence of HIV-1-infected T cell clones can occur through immune reprogramming driven by defective, transcriptionally active proviruses.PLoS Pathog2026https://conductscience.org/library/papers/42900669PubMed
42713136Residual HIV activity and host immunometabolic remodeling during antiretroviral therapy: implications for cardiovascular-kidney-metabolic risk.Front Immunol2026https://conductscience.org/library/papers/42713136PubMed
41864210Multiomic analysis of ART-interruption cohorts identifies cell-extrinsic and -intrinsic mechanisms driving lymphocyte-mediated control of HIV rebound.Immunity2026https://conductscience.org/library/papers/41864210PubMed
41600872Tools to Quantify and Characterize the Persistent Reservoir in People with HIV-1: Focus on Non-B Subtypes.Viruses2026https://conductscience.org/library/papers/41600872PubMed
41143136Meeting Summary for Keystone Symposia on HIV Cure: Antiretroviral Therapy (ART)-Free Control of HIV Infection in Durban, South Africa, 2025.Pathog Immun2025https://conductscience.org/library/papers/41143136PubMed
39903363Phenotyping Viral Reservoirs to Reveal HIV-1 Hiding Places.Curr HIV/AIDS Rep2025https://conductscience.org/library/papers/39903363PubMed
39459922Interventions during Early Infection: Opening a Window for an HIV Cure?Viruses2024https://conductscience.org/library/papers/39459922PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39289508

GET https://conductscience.org/api/papers/v1/39289508/authors